Byrnes Michael 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Mar 27, 2024
Insider Transaction Report
Form 4
Byrnes Michael
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-03-25+112,500→ 112,500 totalExercise: $1.77Exp: 2034-03-24→ Common Stock (112,500 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in thirty-six (36) monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.